House · HR 4541 · 119th Congress
To reauthorize the Young Women’s Breast Health Education and Awareness Requires Learning Young Act of 2009.
Sign in to cast a dissent vote.
Summary
This bill renews two CDC programs focused on breast and cervical cancer. It funds free screenings for low-income and uninsured people through 2030 and extends a breast health education program for young women through 2031. It also gives states more freedom in how they spend grant money.
In Favor
Millions of low-income and uninsured women lack access to cancer screenings. This bill keeps funding in place and lets states spend money in ways that best fit their communities. Catching cancer early saves lives and reduces the cost of treatment later.
Against
The bill reduces reporting rules and gives states more freedom with fewer guardrails. Less oversight could make it harder to know whether the money is reaching the people who need it most. A GAO review is required, but results will not come until 2027 at the earliest.
Additional Considerations
Purpose & Problem
Is the problem real and worth federal action?
The bill extends two CDC programs that support breast and cervical cancer screening, education, and early detection for people with low incomes or no insurance. It also adds goals around reducing gaps in access and screening rates among groups with higher cancer rates.
Scope & Related Provisions
Does it stay focused, or carry unrelated add-ons?
Both titles stay focused on breast and cervical cancer programs. The provisions stay on topic, covering screening access, state grant rules, reporting, and funding for the two named programs.
Who Is Affected
Who benefits, and who bears the cost?
People with low incomes or no insurance who use CDC-funded screening services are the primary group served. States receive grant funds and take on updated reporting duties. The GAO must also produce a new study for Congress.
Cost & Funding
Is it affordable and responsibly funded?
The bill authorizes $235,500,000 per year for fiscal years 2026 through 2030 for the National Breast and Cervical Cancer Early Detection Program. This is an authorized funding level, not a confirmed spending total. No separate cost estimate from CBO is present in the sources.
Risks & Implementation
What could go wrong in practice?
The bill shifts how states may spend grant funds, which requires states to update their programs and reporting. States must also comply with a new five-year reporting schedule rather than the prior annual one, which could create gaps in data for Congress.
For the actual bill text, see congress.gov.
AI-generated · Published 7/25/2026